JP Morgan Chase
XBIT icon

JP Morgan Chase’s XBiotech XBIT Stock Holding History

JP Morgan Chase’s Portfolio XBIT Stock Details XBIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-50,000
Closed -$197K – 5657
2017
Q4 		$197K Buy
+50,000
New +$210K ﹤0.01% 4420

Other funds holding XBIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RC
RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase's XBIT Position: Q1 2026 in Review

JP Morgan Chase reduced its XBiotech (XBIT) stake by 91% in Q1 2026, selling an estimated $2.5K and leaving 96 shares worth $218. The position accounts for ﹤0.01% of the portfolio, ranked #7245.

JP Morgan Chase first reported a position in XBIT in Q2 2016 and has held it in 34 quarters since. The position peaked at $438K in Q1 2021. 37 funds tracked by Wall St. Rank hold XBIT as of Q1 2026.

  • JP Morgan Chase held 96 shares of XBiotech worth $218 as of Q1 2026.
  • JP Morgan Chase sold 1,032 XBiotech shares in Q1 2026, an estimated $2.5K.
  • XBiotech made up ﹤0.01% of JP Morgan Chase's portfolio in Q1 2026, its #7245 holding.
  • JP Morgan Chase first reported a position in XBiotech in Q2 2016 and has held it in 34 quarters since.
  • JP Morgan Chase's XBiotech position peaked at $438K in Q1 2021.
  • 37 funds tracked by Wall St. Rank held XBiotech as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.